Advertisement

Atherosclerosis, an inflammatory and fibroproliferative disease

A prophylactic phytochemical approach with Ginkgo biloba (EGb 761)
      The authors would like to thank Lippi et al. [
      • Lippi G.
      • Targher G.
      • Guidi G.C.
      Ginkgo biloba, inflammation and lipoprotein(a).
      ] for the constructive evaluation of our article published in Atherosclerosis [
      • Rodríguez M.
      • Ringstad L.
      • Schäfer P.
      Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients.
      ] and the positive assessment and allocation of the clinical rank of its results. In complete accordance with these authors, we also think that the reduction in Lp(a) concentration after Ginkgo biloba medication could be mediated by its anti-inflammatory effect.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lippi G.
        • Targher G.
        • Guidi G.C.
        Ginkgo biloba, inflammation and lipoprotein(a).
        Atherosclerosis. 2007; 195: 417-418
        • Rodríguez M.
        • Ringstad L.
        • Schäfer P.
        Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients.
        Atherosclerosis. 2007; 192: 438-444
        • Dangas G.
        • Ambrose J.
        • D’Agate D.
        • et al.
        Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease.
        Am J Cardiol. 1999; 83: 583-585
        • Silaste M.-L.
        • Rantala M.
        • Alfthan G.
        • et al.
        Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a).
        Arterioscler Thromb Vasc Biol. 2004; 24: 498-503
        • Tsimikas S.
        • Lau H.K.
        • Han K.-R.
        • et al.
        Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
        Circulation. 2004; 109: 3164-3170
        • Della Loggia R.
        • Sosa S.
        • Tubaro A.
        • et al.
        Anti-inflammatory activity of some Ginkgo biloba constituents and of their phospholipid-complexes.
        Fitoterapia. 1996; 67: 257-264
        • Chen J.-W.
        • Chen Y.-H.
        • Lin F.-Y.
        • Chen Y.-L.
        • Lin S.-J.
        Ginkgo biloba extract inhibits tumor necrosis factor-α-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells.
        Arterioscler Thromb Vasc Biol. 2003; 23: 1559-1566
        • Ilieva I.
        • Ohgami K.
        • Shiratori K.
        • et al.
        The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo.
        Exp Eye Res. 2004; 79: 181-187
        • Zhou Y.-H.
        • Yu J.-P.
        • Liu Y.-F.
        • et al.
        Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-α, NF-κBp65, IL-6) in TNBS-induced colitis in rats.
        Mediators Inflamm. 2006; 2006: 1-9
        • Lippi G.
        • Braga V.
        • Adami S.
        • Guidi G.
        Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response.
        Clin Chim Acta. 1998; 271: 79-87
        • Lippi G.
        • Guidi G.
        Lipoprotein(a): an emerging cardiovascular risk factor.
        Crit Rev Clin Lab Sci. 2003; 40: 1-42
        • Ramharack R.
        • Barkalow D.
        • Spahr M.A.
        Dominant negative effect of TGF-β1 and TNF-α on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures.
        Arterioscler Thromb Vasc Biol. 1998; 18: 984-990
        • Weiss S.J.
        Tissue destruction by neutrophils.
        N Engl J Med. 1989; 320: 365-376
        • Klebanoff S.J.
        Myeloperoxidase: friend and foe.
        J Leukoc Biol. 2005; 77: 598-625
        • Nomoto K.
        • Oguchi S.
        • Watanabe I.
        • Kushiro T.
        • Kanmatsuse K.
        Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.
        J Cardiol. 2003; 42: 201-206
        • Kameda K.
        • Matsunaga T.
        • Abe N.
        • et al.
        Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling.
        Eur Heart J. 2003; 24: 2180-2185
        • Kong Y.-Z.
        • Yu X.
        • Tang J.-J.
        • et al.
        Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques.
        Atherosclerosis. 2005; 178: 207-215
        • Nadra I.
        • Mason J.C.
        • Philippidis P.
        • et al.
        Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?.
        Circ Res. 2005; 96: 1248-1256
        • Tuomisto K.
        • Jousilahti P.
        • Sundvall J.
        • Pajunen P.
        • Salomaa V.
        C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
        Thromb Haemost. 2006; 95: 511-518
        • Rattazzi M.
        • Faggin E.
        • Bertipaglia B.
        • Pauletto P.
        Innate immunity and atherogenesis.
        Lupus. 2005; 14: 747-751
        • Zhu C.
        • Ying D.
        • Zhou D.
        • et al.
        Expression of TGF-beta1 in smooth muscle cells regulates endothelial progenitor cells migration and differentiation.
        J Surg Res. 2005; 125: 151-156
        • Lotito S.B.
        • Actis-Goretta L.
        • Renart M.L.
        • et al.
        Influence of oligomer chain length on the antioxidant activity of procyanidins.
        Biochem Biophys Res Commun. 2000; 276: 945-951